Tuberculosis (TB) studies meeting inclusion criteria using active finding not including clinically diagnosed TB case
| Study title | Study type | Country | Age (median, IQR) | Male (%) | Setting | Presumptive TB (included/ eligible) | Diagnosed with TB | Not TB | |||||
| Laboratory (bacteriological) | Clinical | Total (%) | HIV | Total (%) | HIV | ||||||||
| Deribew et al (2012)28 | Prevalence of pulmonary TB and spoligotype pattern of Mycobaterium tuberculosis among TB suspects in a rural community in Southwest Ethiopia | Cross-sectional study | Ethiopia | 41* (±16.2) | 39.3 | Community | 428/482 | 17 | 0 | 17 (4) | NR | 411 (96) | NR |
| Hamusse et al (2017)29 | Prevalence and Incidence of Smear-Positive Pulmonary Tuberculosis in the Hetosa District of Arsi Zone, Oromia Regional State of Central Ethiopia | Cross-sectional study | Ethiopia | 33.3* †
(±16) | 51† | Community | 1041/1041 | 43 | 0 | 43 (4) | 0/43 | 998 (96) | NR |
| Merid et al (2019)30 | Population-based screening of pulmonary tuberculosis utilising community health workers in Ethiopia | Cross-sectional study | Ethiopia | 36 29–48 | 35 | Health Centre | 544/544 | 34 | 0 | 34 (6) | 0/31†‡ | 510 (94) | NR |
| Sekandi et al (2014)31 | Yield of undetected tuberculosis and HIV coinfection from active case finding in urban Uganda | Cross-sectional study | Uganda | 24 20–30 | 37.2 | Community | 160/199 | 39 | NR | 39 (24) | 13/39 | 121 (76) | 32 |
*Age, mean (±SD).
†Age and Male (%) of community screened.
‡Not all tested.
NR, not reported.